E
A. Gómez-Palomino et al.
Paper
Synthesis
(S)-4-Benzyl-N-[(S)-2-hydroxy-3-phenylpropanoyl]-5,5-dimethyl-
HRMS (+ESI): m/z [M + Na]+ calcd for C18H21NO4Na: 338.1363; found:
1,3-oxazolidin-2-one (3e)
338.1377.
Prepared according to the General Procedure from (S)-4-benzyl-5,5-
dimethyl-N-(3-phenylpropanoyl)-1,3-oxazolidin-2-one (1e; 168 mg,
0.5 mmol). Purification of the residue by column chromatography
(hexanes–EtOAc, 80:20) afforded 60 mg (0.17 mmol, 34%) of 3e as a
white solid; mp 98–99 °C; [α]D –17.3 (c 1.0, CHCl3); Rf = 0.30 (hex-
anes–EtOAc, 80:20).
(S)-4-Benzyl-N-[(S)-2-hydroxy-5-methoxy-5-oxopentanoyl]-5,5-
dimethyl-1,3-oxazolidin-2-one (3h)
Prepared according to the General Procedure from (S)-4-benzyl-N-(5-
methoxy-5-oxopentanoyl)-5,5-dimethyl-1,3-oxazolidin-2-one (1h;
166 mg, 0.5 mmol). Purification of the residue by column chromatog-
raphy (hexanes–EtOAc, 80:20) afforded 53 mg (0.15 mmol, 30%) of 3h
20
IR (ATR): 3425, 3056, 3025, 2994, 2972, 2914, 1792, 1677, 1352, 1330,
20
1094 cm–1
.
as a white solid; mp 91–93 °C; [α]D –21.0 (c 1.0, CHCl3); Rf = 0.20
(hexanes–EtOAc, 80:20).
IR (ATR): 3466, 2972, 2918, 2851, 1757, 1703, 1352, 1245 cm–1
1H NMR (400 MHz, CDCl3): δ = 7.34–7.22 (5 H, m), 4.97 (1 H, td, J = 7.8,
3.9 Hz), 4.48 (1 H, dd, J = 9.5, 3.8 Hz), 3.68 (3 H, s), 3.68 (1 H, d, J = 7.8
Hz), 3.18 (1 H, dd, J = 14.5, 3.8 Hz), 2.92 (1 H, dd, J = 14.5, 9.5 Hz),
2.61–2.47 (2 H, m), 2.18–2.10 (1 H, m), 2.00–1.91 (1 H, m), 1.42 (3 H,
s), 1.40 (3 H, s).
1H NMR (400 MHz, CDCl3): δ = 7.34–7.23 (10 H, m), 5.28 (1 H, td, J =
7.9, 4.0 Hz), 4.46 (1 H, dd, J = 9.7, 3.7 Hz), 3.46 (1 H, d, J = 7.9 Hz), 3.20
(1 H, dd, J = 14.2, 3.7 Hz), 3.16 (1 H, dd, J = 13.8, 4.0 Hz), 2.92 (1 H, dd,
J = 14.2, 9.7 Hz), 2.88 (1 H, dd, J = 13.8, 7.9 Hz), 1.40 (3 H, s), 1.37 (3 H,
s).
13C NMR (100.6 MHz, CDCl3): δ = 174.2, 152.4, 136.7, 136.5, 129.5,
129.0, 128.7, 128.3, 126.9, 126.7, 83.5, 71.7, 64.0, 40.2, 35.0, 28.5,
22.2.
.
13C NMR (100.6 MHz, CDCl3): δ = 174.1, 173.6, 152.6, 136.5, 128.9,
128.7, 126.9, 83.7, 69.6, 63.9, 51.6, 35.0, 29.4, 28.5 (2 ×), 22.2.
HRMS (+ESI): m/z [M + H]+ calcd for C21H24NO4: 354.1700; found:
HRMS (+ESI): m/z [M + Na]+ calcd for C18H23NO6Na: 372.1418; found:
354.1705.
372.1430.
(S)-4-Benzyl-N-[(S)-2-hydroxy-5-hexenoyl]-5,5-dimethyl-1,3-ox-
azolidin-2-one (3f)
Methyl (S)-2-Hydroxy-3-phenylpropanoate (5)
Prepared according to the General Procedure from (S)-4-benzyl-N-(5-
hexenoyl)-5,5-dimethyl-1,3-oxazolidin-2-one (1f; 150 mg, 0.5
mmol). Purification of the residue by column chromatography (hex-
anes–EtOAc, 80:20) afforded 51 mg (0.16 mmol, 32%) of 3f as a white
solid; mp 90–92 °C; [α]D –15.1 (c 1.0, CHCl3); Rf = 0.30 (hexanes–
EtOAc, 80:20).
A 3.0 M solution of MeMgBr in Et2O (103 μL, 0.31 mmol) was added to
MeOH (1.0 mL) and stirred at 0 °C for 10 min. Then, a solution of 3e
(0.53 g, 0.15 mmol) in 3:1 CH2Cl2–MeOH (1.5 mL) was added to the
former suspension at 0 °C under N2 and the resultant mixture was
stirred for 5 min. The reaction was quenched with 10% w/w aq
NaHSO3 (1 mL) and concentrated in vacuo. The residue was parti-
tioned between 10% w/w aq NaHSO3 (10 mL) and CH2Cl2 (20 mL). The
organic layer was separated and the aqueous layer extracted with
CH2Cl2 (3 × 20 mL). The combined organic extracts were dried
(MgSO4), filtered, and concentrated. Purification by column chroma-
tography (hexanes–EtOAc, 85:15) afforded 31 mg (0.15 mmol, 99% re-
covery) of (S)-benzyl-5,5-dimethyl-1,3-oxazolidin-2-one and 25 mg
20
IR (ATR): 3448, 2994, 2972, 2940, 2990, 2851, 1766, 1703, 1361, 1281
cm–1
.
1H NMR (400 MHz, CDCl3): δ = 7.34–7.22 (5 H, m), 5.84–5.75 (1 H, m),
5.07 (1 H, dq, J = 17.1, 1.6 Hz), 5.01–4.95 (2 H, m), 4.47 (1 H, dd, J = 9.6,
3.7 Hz), 3.52 (1 H, d, J = 7.6 Hz), 3.19 (1 H, dd, J = 14.5, 3.7 Hz), 2.93 (1
H, dd, J = 14.5, 9.6 Hz), 2.29–2.24 (2 H, m), 1.94–1.85 (1 H, m), 1.71–
1.62 (1 H, m), 1.40 (3 H, s), 1.39 (3 H, s).
13C NMR (100.6 MHz, CDCl3): δ = 174.9, 152.4, 137.5, 136.6, 129.0,
128.7, 126.9, 115.3, 83.5, 70.2, 64.0, 35.0, 33.1, 29.4, 28.5, 22.1.
20
(0.14 mmol, 93%) of 5 as a white solid; mp 47–48 °C; [α]D –13.1 (c
1.1, CH2Cl2) {Lit.4a [α]D20 –13.7 (c 1.1, CH2Cl2)}.
IR (ATR): 3271, 3018, 2945, 2838, 1748, 1726, 1425, 1273, 1251, 1087
cm–1
.
HRMS (+ESI): m/z [M + Na]+ calcd for C18H23NO4Na: 340.1519; found:
340.1532.
1H NMR (400 MHz, CDCl3): δ = 7.32–7.20 (5 H, m), 4.45 (1 H, ddd, J =
6.8, 6.1, 4.4 Hz), 3.77 (3 H, s), 3.12 (1 H, dd, J = 13.9, 4.4 Hz), 2.96 (1 H,
dd, J = 13.9, 6.8 Hz), 2.74 (1 H, d, J = 6.1 Hz).
13C NMR (100.6 MHz, CDCl3): δ = 174.5, 136.3, 129.4 (2 ×), 128.4 (2 ×),
126.9, 71.2, 52.4, 40.5.
(S)-4-Benzyl-N-[(S)-2-hydroxy-5-hexynoyl]-5,5-dimethyl-1,3-ox-
azolidin-2-one (3g)
Prepared according to the General Procedure from (S)-4-benzyl-N-(5-
hexynoyl)-5,5-dimethyl-1,3-oxazolidin-2-one (1g; 149 mg, 0.5
mmol). Purification of the residue by column chromatography (hex-
anes–EtOAc, 80:20) afforded 51 mg (0.16 mmol, 32%) of 3g as a white
solid; mp 106–108 °C; [α]D20 –16.4 (c 1.0, CHCl3); Rf = 0.30 (hexanes–
EtOAc, 80:20).
HRMS (+ESI): m/z [M + H]+ calcd for C10H16NO3: 198.1125; found:
198.1116.
(S)-3-Phenyl-1,2-propanediol (6)
A solution of 3e (53 mg, 0.15 mmol) in THF (1 mL) was added to a
solution of NaBH4 (34 mg, 0.9 mmol) in THF–H2O (3:1, 2.2 mL) at 0 °C
under N2 and the resultant mixture was stirred at 0 °C for 50 min. The
reaction was quenched by dropwise addition of aq 2 M HCl/brine
solution until bubbling ceased. The organic layer was separated and
the aqueous layer was extracted with CH2Cl2 (3 × 20 mL). The com-
bined organic layers were washed with brine (10 mL) and the brine
layer was extracted with CH2Cl2 (2 × 10 mL). The combined organic
extracts were dried (MgSO4), filtered, and concentrated. The residue
was purified by column chromatography (hexanes–EtOAc, from 40:60
to 20:80) afforded 30 mg (0.15 mmol, 97% recovery) of (S)-benzyl-
IR (ATR): 3466, 3292, 2949, 2918, 1761, 1699, 1352, 1107 cm–1
.
1H NMR (400 MHz, CDCl3): δ = 7.34–7.22 (5 H, m), 4.99 (1 H, ddd, J =
8.6, 7.1, 3.6 Hz), 4.49 (1 H, dd, J = 9.4, 3.9 Hz), 3.77 (1 H, d, J = 7.1 Hz),
3.18 (1 H, dd, J = 14.5, 3.9 Hz), 2.93 (1 H, dd, J = 14.5, 9.4 Hz), 2.42 (2 H,
td, J = 7.3, 2.6 Hz), 2.10–2.01 (1 H, m), 1.97 (1 H, t, J = 2.6 Hz), 1.87–
1.78 (1 H, m), 1.41 (3 H, s), 1.40 (3 H, s).
13C NMR (100.6 MHz, CDCl3): δ = 173.9, 152.6, 136.4, 129.0, 128.7,
126.9, 83.7, 83.3, 69.5, 68.9, 64.0, 35.0, 32.1, 28.6, 22.2, 14.4.
© Georg Thieme Verlag Stuttgart · New York — Synthesis 2018, 50, A–F